Nature
Rewilding the U.S. could be a powerful tool for addressing climate change
Changes in land use in America could have a big impact on emissions reduction, biodiversity and quality of life, not just in the U.S. but around the world. Here’s what companies should know. Read More
How global pharma GSK is rewriting supplier rules to protect biodiversity
To address its impact on nature and biodiversity, U.K.-based GSK developed sustainable sourcing standards for ingredients such as lactose, gelatin, palm oil, paper and sugar. Read More
Why the market for mopping up ‘forever' chemicals is exploding
Synthetic biology startup Allonnia just raised $30 million more for tech to remediate PFAS. Read More
Is Coca-Cola the worst plastic polluter in the UK?
PepsiCo, McDonald's, Nestlé and others were also featured among the "Dirty Dozen" report on plastic litter by Surfers Against Sewage. Read More
6 ways investors can close the data, metrics gap for nature
Panelists at GreenFin23 offered guidance on how investors can identify and navigate nature dependencies and risks. Read More
Department of Commerce, NOAA launch fund for ocean tech accelerators
The federal government triggers a wave of funding for the ocean tech sector. Read More
3 ways companies fall short on addressing deforestation
A CDP report shows few companies are engaging their entire supply chains on strategies to reduce or eliminate tree cutting, with North American companies at most risk. Read More
'A good day for Europe': EU lawmakers pass landmark nature restoration law
Advocates and business leaders celebrate after the European Parliament narrowly approved the historic ecosystem legislation. Read More
Beyond the yuck factor: Cities turn to ‘extreme’ water recycling
San Francisco is at the forefront of a movement to recycle wastewater from commercial buildings, homes and neighborhoods and use it for toilets and landscaping. This decentralized approach, proponents say, will drive down demand in an era of increasing water scarcity. Read More
AstraZeneca to invest $400M to plant 200 million trees
The global pharmaceuticals giant expands a global reforestation program to support its 2045 net-zero and nature goals. Read More
